MétaCan
Menu
Back to cohort
Record W2782277425 · doi:10.1038/bjc.2017.429

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

2018· article· en· W2782277425 on OpenAlexaff
Christos Mikropoulos, Christina G. Selkirk, Sibel Saya, Elizabeth Bancroft, Emily Vertosick, Tokhir Dadaev, Charles B. Brendler, Elizabeth Page, Alexander Dias, D. Gareth Evans, Jeanette Rothwell, Lovise Mæhle, Karol Axcrona, Kate Richardson, Diana Eccles, Thomas D. Jensen, Palle Jørn Sloth Osther, Christi J. van Asperen, Hans F. A. Vasen, Lambertus A. Kiemeney, Janneke Ringelberg, Cezary Cybulski, Dominika Wokołorczyk, Rachel Hart, Wayne Glover, Jimmy Lam, Louise Taylor, Mónica Salinas, Lídia Feliubadaló, Rogier A. Oldenburg, R.G.H.M. Cremers, Gerald W. Verhaegh, Wendy A. van Zelst-Stams, Jan C. Oosterwijk, Jackie Cook, Derek J. Rosario, Saundra S. Buys, Tom Conner, Susan M. Domchek, Jacquelyn Powers, Margreet G.E.M. Ausems, Manuel R. Teixeira, Sofia Maia, Louise Izatt, Rita K. Schmutzler, Kerstin Rhiem, William D. Foulkes, Talia Boshari, Rosemarie Davidson, Mariëlle Ruijs, Apollonia Tjm Helderman-van den Enden, Lesley Andrews, Lisa Walker, Katie Snape, Alex Henderson, Irene Jobson, Geoffrey J. Lindeman, Annelie Liljegren, Marion Harris, Muriel A. Adank, Judy Kirk, Amy Taylor, Rachel Susman, Rakefet Chen‐Shtoyerman, Nicholas Pachter, Allan D. Spigelman, Lucy Side, Janez Žgajnar, Josefina Móra, Carole Brewer, Neus Gadea, Angela F. Brady, David Gallagher, Theo van Os, Alan Donaldson, Vigdís Stefánsdóttir, Julian Barwell, Paul A. James, Declan G. Murphy, Eitan Friedman, Nicola Nicolai, Lynn Greenhalgh, Elias Obeid, Vedang Murthy, Lucia Copáková, John McGrath, Soo‐Hwang Teo, Sara S. Strom, Karin Kast, Daniel Leongamornlert, Anthony Chamberlain, J. Samuel Pope, Anna Newlin, Neil K. Aaronson, Audrey Ardern‐Jones, Chris Bangma, Elena Castro, David P. Dearnaley, Jórunn E. Eyfjörd, Alison Falconer, Christopher S. Foster, Henrik Grönberg, Freddie C. Hamdy, Oskar T. Johannsson, Vincent Khoo, Jan Lubiński, Eli Marie Grindedal, Joanne McKinley, Kylie Shackleton, Anita Mitra, Clare Moynihan, Gad Rennert, Mohnish Suri, Karen Tricker, Sue Moss, Zsofia Kote‐Jarai, Andrew J. Vickers, Hans Lilja, Brian T. Helfand, Rosalind A. Eeles

Bibliographic record

VenueBritish Journal of Cancer · 2018
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Diagnosis and Treatment
Canadian institutionsMcGill UniversityMcGill Genome CentreMcGill University Health Centre
FundersNational Cancer InstituteEuropean Regional Development FundInstituto de Salud Carlos IIICancer Council TasmaniaSidney Kimmel Center for Prostate and Urologic CancersVetenskapsrådetJavna Agencija za Raziskovalno Dejavnost RSRoyal Marsden NHS Foundation TrustProstate Cancer Foundation of AustraliaGeneralitat de CatalunyaNational Institute for Health and Care ResearchNorthShore University HealthSystemVictorian Cancer AgencyCancer AustraliaCancerfondenCentro de Investigación Biomédica en Red de CáncerProstate Cancer FoundationMyriad GeneticsCancer Research UK
KeywordsProstate cancerProstate-specific antigenMedicineGenetic predispositionProstateProspective cohort studyOncologyAntigenInternal medicineCancerImmunologyDisease

Abstract

fetched live from OpenAlex

BACKGROUND: Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa). The IMPACT study is evaluating PSA screening in men with a known genetic predisposition to PrCa due to BRCA1/2 mutations. This analysis evaluates the utility of PSA and PSAV for identifying PrCa and high-grade disease in this cohort. METHODS: PSAV was calculated using logistic regression to determine if PSA or PSAV predicted the result of prostate biopsy (PB) in men with elevated PSA values. Cox regression was used to determine whether PSA or PSAV predicted PSA elevation in men with low PSAs. Interaction terms were included in the models to determine whether BRCA status influenced the predictiveness of PSA or PSAV. RESULTS: , PSAV was not significantly associated with presence of cancer or high-grade disease. PSAV did not add to PSA for predicting time to an elevated PSA. When comparing BRCA1/2 carriers to non-carriers, we found a significant interaction between BRCA status and last PSA before biopsy (P=0.031) and BRCA2 status and PSAV (P=0.024). However, PSAV was not predictive of biopsy outcome in BRCA2 carriers. CONCLUSIONS: PSA is more strongly predictive of PrCa in BRCA carriers than non-carriers. We did not find evidence that PSAV aids decision-making for BRCA carriers over absolute PSA value alone.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.002
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.285
Teacher spread0.272 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations20
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueBritish Journal of CancerSame topicProstate Cancer Diagnosis and TreatmentFrench-language works237,207